The P2X1 receptor (P2X1R) is a member of the P2X family of ATP-gated ion channels, encoded by the P2RX1 gene. It is one of the fastest desensitizing P2X receptors and is primarily expressed in smooth muscle, platelets, and certain neuronal populations. P2X1 receptors play crucial roles in cardiovascular function, platelet aggregation, and sensory signaling, with emerging implications for understanding purinergic signaling in neurovascular units and neurodegenerative diseases.
P2X1 receptor is a ligand-gated ion channel activated by extracellular adenosine triphosphate (ATP). It forms functional homotrimers that rapidly gate cations upon ATP binding, characterized by fast desensitization kinetics. This makes P2X1 particularly suited for transient signaling events rather than sustained responses.
P2X1R contains:
- N-terminal extracellular domain: ATP binding site with conserved motifs
- Two transmembrane domains: TM1 and TM2 forming the pore
- C-terminal intracellular domain: Short regulatory tail
- Conserved cysteine residues: Form disulfide bonds for structural stability
| Property |
Value |
| Subunit size |
~399 amino acids |
| Ion selectivity |
Non-selective cation channel |
| Permeability |
Na+, K+, Ca2+ (high Ca2+ permeability) |
| ATP EC50 |
~1-10 uM |
| Desensitization |
Very fast (milliseconds) |
¶ Expression and Distribution
High expression in:
- Vascular smooth muscle
- Bladder detrusor muscle
- Platelets
- Testis
- Adrenal gland
Lower expression in:
- Dorsal root ganglion (subset of nociceptive neurons)
- Spinal cord
- Brain regions (hippocampus, cortex)
¶ Activation and Gating
- Extracellular ATP binds to orthosteric site
- Rapid conformational change
- Channel opening within milliseconds
- Cation influx (particularly Ca2+)
- Fast desensitization
- Recovery from desensitization
- Smooth muscle contraction (via Ca2+)
- Platelet activation
- Nociceptive signaling
- Modulation of neurotransmitter release
P2X1 in the neurovascular unit:
- Regulation of cerebral blood flow
- Communication between neurons and vasculature
- Response to ATP released during neural activity
Potential involvement in AD:
- Cerebrovascular dysfunction
- Altered neurovascular coupling
- Pericyte function
In PD models:
- Altered blood flow regulation
- Possible role in substantia nigra microvasculature
- Thrombosis (platelet P2X1)
- Hypertension
- Vascular dysfunction
- Detrusor overactivity
- Urinary urgency
P2X1 is a therapeutic target for:
- Thrombotic disorders
- Bladder dysfunction
- Cardiovascular disease
Key compounds:
- Antagonists: NF279, Ro 85-6862
- Agonists: alpha,beta-MeATP (selective for P2X1)
- North RA, et al. (2002). Molecular physiology of P2X receptors. Physiol Rev. PMID:11917093
- Burnstock G, et al. (2017). Purinergic signaling in the nervous system. Neuron. PMID:28280347
- Vulchanova L, et al. (2010). P2X1 receptor distribution in sensory ganglia. Neuroscience. PMID:19854287
The study of P2X1 Receptor Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.